N-Nitroso dabigatran Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds .Dabigatran is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults and children 3 months of age and older who have been treated with an injectable anticoagulant ('blood thinner').N-Nitroso Dabigatran Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Dabigatran Impurity 1 CAS NO: 2892260-29-4 also known as N-Nitroso Dabigatran Etexilate or N-Nitroso dabigatran Impurity & it is chemically represented as ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. Synchemia is the leading manufacturing and exporter of N-Nitroso Dabigatran Impurity 1 .We supply N-Nitroso Dabigatran Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141411 |
| CAS No | NA |
| Mol.F. | C10H13ClN2O : HCl |
| Mol.Wt. | 212.7 : 36.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141412 |
| CAS No | NA |
| Mol.F. | C10H12N2O |
| Mol.Wt. | 176.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141413 |
| CAS No | 500545-48-2 |
| Mol.F. | C15H26ClN3O2 |
| Mol.Wt. | 315.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141414 |
| CAS No | NA |
| Mol.F. | C3H9N3O3S |
| Mol.Wt. | 167.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141415 |
| CAS No | NA |
| Mol.F. | C7H9N3O |
| Mol.Wt. | 151.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141416 |
| CAS No | NA |
| Mol.F. | C26H28Cl2N6O4 |
| Mol.Wt. | 559.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141417 |
| CAS No | NA |
| Mol.F. | C14H20N4O5 |
| Mol.Wt. | 324.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141418 |
| CAS No | NA |
| Mol.F. | C25H28Cl2N6O5 |
| Mol.Wt. | 563.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141419 |
| CAS No | NA |
| Mol.F. | C26H30Cl2N6O5 |
| Mol.Wt. | 577.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141420 |
| CAS No | NA |
| Mol.F. | C25H26Cl2N6O4 |
| Mol.Wt. | 545.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141421 |
| CAS No | NA |
| Mol.F. | C21H18Cl2N4O4 |
| Mol.Wt. | 461.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141422 |
| CAS No | NA |
| Mol.F. | C34H26N4O6 |
| Mol.Wt. | 586.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141424 |
| CAS No | NA |
| Mol.F. | C12H17N3O3 |
| Mol.Wt. | 251.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141425 |
| CAS No | NA |
| Mol.F. | C18H17N5O |
| Mol.Wt. | 319.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141423 |
| CAS No | NA |
| Mol.F. | C13H17N3O5 |
| Mol.Wt. | 295.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141426 |
| CAS No | NA |
| Mol.F. | C32H27N5O3 |
| Mol.Wt. | 529.6 |
| INV STATUS | CUSTOM SYNTHESIS |